Healthcare Prescribing Policy

Healthcare Prescribing Policy

Practice Identification and Policy Control

Effective Date:   Review Date:

Purpose

This policy establishes uniform standards for the prescribing, documentation, dispensing oversight, and monitoring of prescription medications, including controlled substances, to promote patient safety, reduce medication-related harm, and ensure compliance with applicable statutory and professional obligations.

Scope

This policy applies to all licensed prescribers, clinical staff authorized to issue prescriptions, and delegated personnel at the practice in all care settings.

Definitions

For purposes of this policy, "prescriber" means any clinician authorized by licensure and organizational privileging to issue prescriptions; "controlled substance" means a medication regulated by law which may carry addiction potential; "treatment agreement" means a documented, signed plan between clinician and patient addressing expectations and safeguards for medication therapy.

Prescriber Qualifications and Authorization

Prescribers must hold current, unrestricted licensure and any required registration or authorization to prescribe controlled substances. Prescribers shall maintain documentation of credentials, professional license number, and prescribing registrations in the personnel file.

Patient Assessment and Documentation Requirements

Prior to initiating or renewing a prescription, prescribers must perform and document a clinical assessment that supports the indication for therapy. Documentation must include diagnosis, relevant medical history, medication reconciliation, allergies, risk assessment for misuse, treatment goals, and monitoring plan.

Checklist (to be completed and retained in the medical record):

History and indication documented
Medication reconciliation completed
Allergies and adverse reactions documented
Risk assessment for misuse/diversion completed

Controlled Substances and Opioid Prescribing

Prescribing controlled substances must follow heightened safeguards. Short-term acute therapy should be limited to the lowest effective dose and shortest duration consistent with the clinical condition. For chronic therapy, prescribers must document a written treatment plan including therapeutic goals, functional outcomes, and periodic re-assessment.

Specific requirements include, where clinically applicable:

Electronic Prescribing and Transmission

Electronic prescribing is the standard method for transmitting prescriptions. When electronic transmission is not possible, prescribers must use secure, documented alternatives in accordance with professional standards. Prescriptions must contain sufficient instructions to ensure safe dispensing and administration.

Electronic prescribing required except where clinically or technically infeasible

Prescription Monitoring and Review

Prior to initiating or renewing prescriptions for potentially habit-forming medications, prescribers shall review available prescription history information as required by law and as a component of the risk assessment. Documentation of the review and any resulting clinical decisions shall be included in the medical record.

Refills, Renewals and Early Requests

Refills and renewals must be issued only after clinical reassessment where indicated. Controlled substances shall not be refilled beyond limits established by law and this policy; prescribers must document rationale for any early refill or deviation from standard refill restrictions.

Delegation, Supervision and Standing Orders

Delegation of prescribing-related tasks to non-prescribing personnel (e.g., routing renewals, prescription entry) must be performed pursuant to written protocols and under the supervision of an authorized prescriber. Final authorization of prescriptions remains the responsibility of the prescriber.

Recordkeeping, Retention and Auditing

All prescribing-related documentation must be retained in the medical record in accordance with organizational retention schedules and applicable legal requirements. The practice will conduct periodic audits to ensure adherence to this policy; prescribers must cooperate with audits and corrective action.

Patient Education and Informed Consent

Prescribers shall inform patients about the indication, expected benefits, common side effects, risks of dependence or misuse (where relevant), safe storage and disposal, and alternatives. When long-term opioid therapy or other high-risk medications are initiated, the prescriber shall document informed consent and consider a written treatment agreement.

Written treatment agreement required for chronic opioid therapy or other high-risk medications

Privacy and Confidentiality

All prescribing records are confidential and must be handled in accordance with applicable privacy laws and organizational policies. Access to prescribing records is limited to authorized personnel for legitimate clinical or compliance purposes.

Noncompliance, Reporting and Corrective Action

Violations of this policy may result in disciplinary action, up to and including suspension of prescribing privileges, termination of employment, and reporting to appropriate licensing authorities as required. Reasons for corrective action include unsafe prescribing, failure to document required assessments, and evidence of diversion.

Policy Review and Amendments

This policy will be reviewed at intervals specified above or sooner in response to changes in law, clinical standards, or organizational needs. Amendments require approval by the policy owner or designated governing authority.

Acknowledgment of Responsibility

By signing below, the signatory affirms that they have authority to implement and enforce this policy within the practice and that they will ensure dissemination to affected staff. The signatory certifies that to the best of their knowledge the policy conforms to applicable professional and legal standards.

Sign Now